D-1844-2019 Class II Terminated

Recalled by Macleods Pharma Usa Inc — Plainsboro, NJ

FDA drug recall D-1844-2019 was initiated by Macleods Pharma Usa Inc on Jul 17, 2019 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Feb 9, 2021). Affected quantity: a) 5448 bottles b) 972 bottles c) 158 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 21, 2019
Initiation Date
Jul 17, 2019
Termination Date
Feb 9, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 5448 bottles b) 972 bottles c) 158 bottles

Product description

Tamsulosin Hydrochloride Capsules, USP 0.4 mg Rx only a) 100 count (NDC 33342-159-11), b) 500 count (NDC 33342-159-15) and c) 1000 count (NDC 33342-159-44) bottles, Manufactured : Macleods Pharma USA, Inc Plainsboro, NJ Manufactured by: Macleods Pharmaceuticals Ltd Baddi, Himchal Pradesh, INDIA

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide

Code information

a) BTP803A, exp 08/2020; b) BTP802A, exp 07/2020, BTP901A, exp 12/2020; c) BTP802B, exp 07/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1844-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1844-2019. Report a data issue: hello@regdatalab.com.